You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nab-paclitaxel

Showing 26 - 50 of 338
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
Mar 15, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Withdrawn
  • Anatomic Stage III Breast Cancer AJCC v8
  • +11 more
  • (no location specified)
Jan 5, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial (Toripalimab, Epirubicin, High Intensity Focused Ultrasoun)

Not yet recruiting
  • Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
Aug 5, 2022

Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting
  • Resectable Cholangiocarcinoma
  • +5 more
  • Atlanta, Georgia
  • +6 more
Oct 5, 2022

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV Trial (SBP-101, Nab-paclitaxel,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • +2 more
  • (no location specified)
Feb 21, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Nab-paclitaxel
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Pancreas Cancer Trial in New York (Bethanechol, Gemcitabine, nab-paclitaxel)

Recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Medical Center
Feb 3, 2022

Breast Cancer Invasive Trial in Shanghai (Pyrotinib, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer Invasive
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Cancer
  • SGT-53
  • +2 more
  • Dallas, Texas
    Mary Crowley Cancer Research Center
Feb 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Beijing (nab-paclitaxel, Cisplatin, Capecitabine)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • nab-paclitaxel
  • +2 more
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 13, 2022

Pancreatic Cancer Trial in Shanghai (SHR6390, Nab-paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jan 10, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

Recruiting
  • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Mar 9, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

NSCLC Trial (Pembrolizumab, Paclitaxel, Nab-paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Jan 20, 2022

Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

Completed
Has Results
  • Neoplasms
  • Pancreatic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 16, 2022

Metastatic Breast Cancer Trial in New York (PU-H71, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 17, 2021

Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic

Recruiting
  • Pancreas Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Gemcitabine 1000 mg
  • +2 more
  • Loma Linda, California
    Loma Linda University Health
Jun 14, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)

Active, not recruiting
  • Pancreatic Cancer
  • Advanced Pancreatic Ductal Adenocarcinoma
  • Hartford, Connecticut
  • +9 more
Jul 15, 2022

Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

Terminated
  • Cancer of Pancreas
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Sep 26, 2022

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022